RADX Stock Analysis: Buy, Sell, or Hold?
RADX - Radiopharm Theranostics Limited American Depositary Shares
$4.38
0.07 (1.62%)
▲
5d:
-1.57%
30d:
-4.78%
90d:
-5.6%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Feb 26, 2026
0d
Get Alerted When RADX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RADX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RADX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RADX is currently trading at $4.38, which is considered slightly low relative to its 30-day fair value range of $4.33 to $4.63.
Technical Outlook: Technically, RADX is in a strong downtrend. Immediate support is located at $4.04, while resistance sits at $4.79.
Market Sentiment: RADX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $16.92 (+286.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RADX is in a strong downtrend. Immediate support is located at $4.04, while resistance sits at $4.79.
Market Sentiment: RADX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $16.92 (+286.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$4.33 -
$4.63
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 286.2% below Wall St target ($16.92)
Trading Range Analysis
30-Day Trading Range
$4.33 -
$4.63
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$4.04
Resistance Level
$4.79
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.00
Wall Street Target
$16.92
(+286.2%)
Revenue Growth (YoY)
154.5%
Profit Margin
-286.2%
Share & Embed Analysis
Last updated: June 24, 2026 9:08 AM ET
Data refreshes hourly during market hours. Next update: 10:08 AM
Data refreshes hourly during market hours. Next update: 10:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RADX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
